MARKET

VSTM

VSTM

Verastem
NASDAQ
8.64
+0.93
+12.00%
Opening 12:19 10/15 EDT
OPEN
8.04
PREV CLOSE
7.71
HIGH
8.67
LOW
7.77
VOLUME
5.03M
TURNOVER
--
52 WEEK HIGH
10.82
52 WEEK LOW
3.430
MARKET CAP
782.02M
P/E (TTM)
-3.5112
1D
5D
1M
3M
1Y
5Y
1D
RBC Capital Maintains Outperform on Verastem, Raises Price Target to $19
Benzinga · 1h ago
Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 3h ago
Verastem price target raised to $19 from $14 at RBC Capital
TipRanks · 4h ago
Verastem: A Real Pancreatic Cancer Drug, Arriving Second
Seeking Alpha · 4h ago
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Verastem (VSTM)
TipRanks · 5h ago
Analysts’ Top Healthcare Picks: Verastem (VSTM), Rezolute (RZLT)
TipRanks · 6h ago
BTIG Maintains Buy on Verastem, Raises Price Target to $24
Benzinga · 6h ago
Verastem Announces $234 Million Oncology Financing Transaction
TipRanks · 18h ago
More
About VSTM
Verastem, Inc. is a late-stage development biopharmaceutical company, which focuses on the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (RAS)/ mitogen-activated pathway kinase (MAPK) pathway-driven cancers. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.

Webull offers Verastem Inc stock information, including NASDAQ: VSTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VSTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VSTM stock methods without spending real money on the virtual paper trading platform.